Latest Regulatory Milestones News

Recce Pharmaceuticals has completed a A$15.8 million capital raise to fund pivotal Phase 3 clinical trials and progress its FDA application, positioning the company for potential commercial breakthroughs in antibiotic-resistant infections.

EMVision Medical Devices has activated two additional key sites in its pivotal trial for the emu™ bedside brain scanner, advancing its path toward FDA clearance. These new sites join a growing network of leading stroke centres across the US and Australia.

Cardiex Limited has gained Therapeutic Goods Administration approval for its CONNEQT Pulse device, paving the way for commercial expansion in Australia alongside its established US presence.

Manuka Resources’ Taranaki VTM Project has advanced through a critical regulatory checkpoint, with no competing applications or appeals standing in its way, moving closer to expert panel determination.

Equinox Resources has obtained a crucial exploration permit for its Alturas Antimony Project in British Columbia, paving the way for a comprehensive 2025 field program and potential bulk sampling. This milestone advances the company’s strategy amid rising North American demand for critical minerals.

The Arkansas Oil & Gas Commission has approved a 2.5% lithium royalty for brine projects, providing Pantera Lithium with regulatory clarity and a competitive fiscal framework that enhances its Smackover Project’s commercial prospects.

Aston Minerals Limited shares will be suspended from trading following court approval of its acquisition by Torque Metals Limited. This marks a significant step in the consolidation of mining assets in Western Australia.

Sipa Resources has completed key heritage surveys and submitted environmental approvals, setting the stage for maiden drilling at its South Australian gold projects near the 1.6 million ounce Tunkillia deposit.

Titanium Sands Limited has secured one-year retentions for four high-grade exploration licenses, enabling critical environmental studies and paving the way for a mining license application in Sri Lanka.

Neuren Pharmaceuticals posted record 2024 financials driven by DAYBUE royalties and advanced NNZ-2591 into Phase 3 trials, while launching a $50 million share buy-back amid volatile market sentiment.

Piche Resources has received formal environmental approval to begin its maiden drilling campaign at the Cerro Chacon gold-silver project in Argentina, targeting a 14 km mineralised corridor with 57 planned drill holes.

PainChek Limited has secured a pivotal reseller and integration deal with Eldermark Software, positioning its AI-driven pain assessment app for a major US market rollout pending FDA approval.